2,107 results on '"Kuo, Hann-Chorng"'
Search Results
2. Purine nucleoside phosphorylase as a target for the treatment of interstitial cystitis/bladder pain syndrome with and without Hunner lesions
3. Risk factors of video urodynamics and bladder management for long-term complications in patients with chronic spinal cord injury
4. Combination of urinary biomarkers and machine-learning models provided a higher predictive accuracy to predict long-term treatment outcomes of patients with interstitial cystitis/bladder pain syndrome
5. Treatment Patterns with Mirabegron and Antimuscarinics for Overactive Bladder: A Prospective, Registry Study in Taiwan and South Korea (FAITH)
6. Management of spinal cord injury patients with neurogenic lower urinary tract dysfunction using minimally invasive and surgical therapies in Taiwan
7. Bladder Pain Syndrome Associated with Interstitial Cystitis: Recent Research and Treatment Options
8. Management of Patients with Detrusor Hyperactivity with Impaired Contractility
9. The Role of Viral Infection in the Pathogenesis of Interstitial Cystitis/Bladder Pain Syndrome
10. Bladder neck incompetence could be an etiology of overactive bladder syndrome in women with stress urinary incontinence after anti-incontinence surgery: insights from transrectal sonography
11. Low detrusor contractility has a less favorable outcome of anti-incontinence surgery for women with stress urinary incontinence
12. Efficacy of single and repeated transurethral bladder neck incisions for female voiding dysfunction
13. Performance of urinary biomarkers in differentiating dysfunctional voiding in women with overactive bladder syndrome: a prospective pilot study
14. Surgical outcome of male patients with chronic central nervous system disorders and voiding dysfunction due to bladder outlet obstruction
15. Clinical presentation, videourodynamic characteristics, and treatment outcome in men with interstitial cystitis-like lower urinary tract symptoms
16. Usefulness of videourodynamic study in the decision-making of surgical intervention and bladder management for neurogenic lower urinary tract dysfunction among patients with myelomeningocele
17. First reported study of daily, high dose transdermal application of oxybutynin in a humid country
18. Therapeutic efficacy and cognitive adverse events of overactive bladder medication in patients with central nervous system Disorders—A cohort study
19. Bladder Dysfunction in Older Adults: The Botulinum Toxin Option
20. Treatment outcomes of detrusor underactivity in women based on clinical and videourodynamic characteristics
21. Effect of videourodynamic subtypes on treatment outcomes of female dysfunctional voiding
22. Diagnostic and prognostic value of urine biomarkers among women with dysfunctional voiding
23. Therapeutic outcome of active management in male patients with detrusor underactivity based on clinical diagnosis and videourodynamic classification
24. Nocturia, nocturnal polyuria, and nocturnal enuresis in adults: What we know and what we do not know
25. Lower urinary tract dysfunction in the central nervous system neurogenic bladder and the real-life treatment outcome of botulinum toxin A
26. MP23-04 BLADDER NECK INCOMPETENCE AS A POTENTIAL ETIOLOGY OF OVERACTIVE BLADDER SYNDROME IN WOMEN WITH STRESS URINARY INCONTINENCE AFTER ANTI-INCONTINENCE SURGERY—INSIGHTS FROM TRANSRECTAL SONOGRAPHY
27. Predictors of further anti-incontinence interventions or transvaginal urethrolysis after a pubovaginal sling procedure in women with and without neurologic disorders
28. Bladder outlet surgery is effective only in patients with central nervous system disorders and voiding dysfunction proven to be obstructed
29. Using Urine Biomarkers to Differentiate Bladder Dysfunctions in Women with Sensory Bladder Disorders.
30. Predictive Factors for the Successful Outcome of Urethral Sphincter Injections of Botulinum Toxin A for Non-Neurogenic Dysfunctional Voiding in Women.
31. The Pathomechanism and Current Treatments for Chronic Interstitial Cystitis and Bladder Pain Syndrome.
32. Efficacy of Urethral Sphincter Botulinum Toxin A Injection in Patients with Spinal Cord Injury with Dysuria: A Retrospective Cohort Study.
33. Impact of Urethral Sphincter Electrophysiology on Botulinum Toxin A Treatment in Women with Non-Neurogenic Dysfunctional Voiding.
34. Real-Life Treatment Outcome of Botulinum Toxin A Injection on Overactive Bladder and Voiding Dysfunction in Patients with Central Nervous System Lesions
35. Hypermethylation Loci of ZNF671, IRF8, and OTX1 as Potential Urine-Based Predictive Biomarkers for Bladder Cancer
36. Intravesical Botulinum Toxin Injection Plus Hydrodistention Is More Effective in Patients with Bladder Pain-Predominant Interstitial Cystitis/Bladder Pain Syndrome
37. Obstructive patterns in videourodynamic studies predict responses of female dysfunctional voiding treated with or without urethral botulinum toxin injection: a long-term follow-up study
38. Current Role of Neurourologic Evaluation in Interstitial Cystitis/Bladder Pain Syndrome
39. A novel management for postprostatectomy urinary incontinence: platelet-rich plasma urethral sphincter injection
40. Cystoscopic hydrodistention characteristics provide clinical and long-term prognostic features of interstitial cystitis after treatment
41. Smaller bladder capacity and stronger bladder contractility in patients with ketamine cystitis are associated with elevated TRPV1 and TRPV4
42. Urine biomarkers in ESSIC type 2 interstitial cystitis/bladder pain syndrome and overactive bladder with developing a novel diagnostic algorithm
43. Therapeutic efficacy of biofeedback pelvic floor muscle exercise in women with dysfunctional voiding
44. Identifying occult bladder outlet obstruction in women with detrusor-underactivity-like urodynamic profiles
45. Difference in electron microscopic findings among interstitial cystitis/bladder pain syndrome with distinct clinical and cystoscopic characteristics
46. The Tumor Necrosis Factor-α Level in Platelet-Rich Plasma Might Be Associated with Treatment Outcome in Patients with Interstitial Cystitis/Bladder Pain Syndrome or Recurrent Urinary Tract Infection
47. Urine biomarker could be a useful tool for differential diagnosis of a lower urinary tract dysfunction
48. Multimodal therapies and strategies for the treatment of interstitial cystitis/bladder pain syndrome in Taiwan
49. Epstein-Barr Virus as a Potential Etiology of Persistent Bladder Inflammation in Human Interstitial Cystitis/Bladder Pain Syndrome
50. Molecular Characteristics of Underactive Bladder
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.